Edition:
India

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

6.19USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$6.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,188
52-wk High
$21.59
52-wk Low
$5.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 3 0.73 2.19 0.00 0.00
Year Ending Dec-18 4 1.10 4.40 0.00 1.25
Year Ending Dec-19 4 2.20 8.80 0.00 2.50
Earnings (per share)
Quarter Ending Jun-18 4 -0.58 -0.45 -0.71 -0.71
Quarter Ending Sep-18 4 -0.75 -0.60 -0.96 -0.84
Year Ending Dec-18 5 -2.99 -2.13 -4.15 -2.75
Year Ending Dec-19 5 -3.43 -1.63 -5.93 -2.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -66.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.63%
# of Holders: 36
Total Shares Held: 2,934,647
3 Mo. Net Change: 249,360
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.